Semax Research — Stemcode Peptides

Semax

Synthetic Heptapeptide

Semax is a synthetic heptapeptide derived from the ACTH(4-7) fragment with a Pro-Gly-Pro C-terminal extension. Developed at the Institute of Molecular Genetics in Moscow, it has been studied for nootropic and neuroprotective properties.

BDNF Expression

Neuroprotection

Cognitive Function

Neuroplasticity

Quantified findings reported in the literature

amino acid residues in the Semax heptapeptide sequence

Ashmarin et al., 1995

verified purity by HPLC analysis in every Stemcode batch

Stemcode Peptides COA data

Published, peer-reviewed studies

A nootropic adrenocorticotropin analog 4-10-semax (15 years experience in its design and study)

Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency

Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus

Study demonstrating Semax-induced upregulation of BDNF and its receptor TrkB in rat hippocampus and cortex, supporting neuroprotective mechanisms.

Third-party analytical reports

Certificates of Analysis from independent laboratories for products supplied by Stemcode. Reported values describe the analysed material; they are reported as documented and are distinct from the published literature above.

Stemcode supplies Semax as a research-grade compound for laboratory research use only — not for human or animal consumption.